NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 9, 1998, Pages 803-813

  Mizisin, Andrew P ^a,c   Kalichman, Michael W ^a   Bache, Maryanne ^a   Dines, Kevin C ^a   Distefano, Peter S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aldose reductase; Galactose intoxication; Neurotrophin 3; Peripheral nerve; Polyol pathway; Skeletal muscle

Indexed keywords

ALDEHYDE REDUCTASE; CILIARY NEUROTROPHIC FACTOR; GALACTOSE; NEUROTROPHIN 3; POLYOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERGLYCEMIA; INSULIN DEFICIENCY; MOTOR NERVE CONDUCTION; MYELINATED NERVE; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SENSORY NERVE; SKELETAL MUSCLE; SURAL NERVE; VENTRAL ROOT;

EID: 0031709130     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199809000-00001     Document Type: Article

References (56)

1. Gabbay KH, Merola LO, Field RA. Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes. Science 1966;151:209-10
2. Tomlinson DR, Willars GB, Carrington AL. Aldose reductase inhibitors and diabetic complications. Pharmacol Ther 1992;54:151-94
3. Tomlinson DR. The pharmacology of diabetic neuropathy. Diabetes Metab Rev 1994;8:67-84
4. Chakrabarti S, Sima AAF, Nakajima T, Yagihashi S, Greene DA. Aldose reductase in the BB rat: Isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 1987;30:244-51
5. Gabbay KH, O'Sullivan JB. The sorbitol pathway-enzyme localization and content in normal and diabetic nerve and cord. Diabetes 1968;17:239-43
6. Kern TS, Engerman RL. Immunohistochemical distribution of aldose reductase. Histochem J 1982;14:507-15
7. Ludvigson MA, Sorenson RL. Immunohistochemical localization of aldose reductase. I. Enzyme purification and antibody preparation-localization in peripheral nerve, artery and testis. Diabetes 1980;29:438-49
8. +-dependent p-nitro-phenylphosphatase in rat peripheral nerve. Acta Neuropathol 1991;81:529-39
9. Cameron NE, Cotter MA, Robertson S, Cox D. Muscle and nerve dysfunction in rats with experimental galactosaemia. Exp Physiol 1992;77:89-108
10. Tomlinson DR, Holmes PR, Mayer JH. Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett 1982;31:189-93
11. Willars GB, Calcutt NA, Tomlinson DR. Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats. J Neurol Sci 1991;104:46-51
12. Yagihashi S, Kamijo M, Ido Y, Mirrlees DJ. Effects of long term aldose reductase inhibition on experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozotocin-induced diabetic rats. Diabetes 1990;39:690-96
13. Mizisin AP, Powell HC. Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 1993;52:78-86
14. Calcutt NA, Muir D, Powell HC, Mizisin AP. Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res 1992;575:320-24
15. Mizisin AP, Calcutt NA, DiStefano PS, Longo FM. Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes 1997;46: 647-52
16. Hellweg R, Hartung H-D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990;26:258-67
17. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR. Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 1995;64:1231-37
18. Rodriguez-Pena A, Botana M, Gonzalez M, Requejo F. Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats. Neurosci Lett 1995;200:37-40
19. Ihara C, Shimatsu A, Mizuta H, Murabe H, Nakamura Y, Nakao K. Decreased neurotrophin-3 expression in skeletal muscles of streptozotocin-induced diabetic rats. Neuropeptides 1996;30: 309-12
20. Mizisin AP, Bache M, DiStefano PS, Acheson A, Lindsay RM, Calcutt NA. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. J Neuropathol Exp Neurol 1997;56: 1290-1301
21. Gold BG, Mobley WC, Matheson SF. Regulation of axonal caliber, neurofilament content and nuclear localization in mature sensory neurons by nerve growth factor. J Neurosci 1991;11:943-55
22. Hayes RI, Yang K, Whitson JS, et al. Rescue of injury-induced neurofilament loss by BDNF gene transfection in primary septohippocampal cell cultures. Neurosci Lett 1995;191:121-25
23. Willars GB, Lambourne JE, Tomlinson DR. Does galactose feeding provide a valid model of consequences of exaggerated polyolpathway flux in peripheral nerve in diabetes? Diabetes 1987;36: 1425-31
24. Kalichman MW, Powell HC, Calcutt NA, Mizisin AP. Mast cell degranulation and blood-nerve barrier permeability of rat sciatic nerve after seven days of hyperglycemia. Am J Physiol 1995;268: H740-48
25. DiStefano PS, Friedman B, Radziejewski C, et al. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992;8: 983-93
26. Mizisin AP, Dines KC, Kalichman MW, Bache M, Lindsay RM, DiStefano PS. Effects of NT-3 treatment on galactose-induced neuropathy. Soc Neurosci Abs 1996;22:1000
27. Helgren ME, Cliffer KD, Torrento K, et al. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. J Neurosci 1997;17:372-82
28. Stanley EF. Sensory and motor nerve conduction velocities and the latency of the H reflex during growth of the rat. Exp Neurol 1981;71:497-506
29. de Koning P, Gispen WH. Org. 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 1987;8:415-22
30. Forcier NJ, Mizisin AP, Rimmer MA, Powell HC. Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol Exp Neurol 1991;50:235-55
31. Tomlinson DR, Fernyhough P, Diemel LT. Neurotrophins and peripheral neuropathy. Phil Trans Royal Soc Lond Series B: Biol Sci 1996;351:455-62
32. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR. Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol Brain Res 1994;21:171-75
33. Maisonpierre PC, Belluscio L, Friedman B, et al. NT-3, BDNF and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron 1990;5:501-9
34. Klein R, Silos-Santiago I, Smeyne RJ, et al. Disruption of the neurotrophin-3 receptor gene trkC eliminates Ia muscle afferents and results in abnormal movements. Nature 1994;368:249-51
35. Kucera J, Fan G, Jaenisch R, Linnarsson S, Ernfors P. Dependence of developing Ia afferents on neurotrophin-3. J Comp Neurol 1995;363:307-20
36. Copray JC, Brouwer N. Selective expression of neurotrophin-3 mRNA in muscle spindles of the rat. Neuroscience 1994;63: 1125-35
37. Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993;363:266-70
38. Yan Q, Elliot JL, Matheson C, et al. Influences of neurotrophins on mammalian motoneruons in vivo. J Neurobiol 1993;24:1555-77
39. Jakobsen J. Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves. Diabetologia 1976;12:539-46
40. Jakobsen J. Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats. J Neurol Neurosurg Psychiat 1979;42:509-18
41. Nukada H, Dyck PJ, Low PA, Lais AC, Sparks MF. Axonal caliber and neurofilaments are proportionately decreased in galactose neuropathy. J Neuropathol Exp Neurol 1986;45:140-50
42. McLean WG, Pekiner C, Cullum NA, Casson IF. Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes. Mol Neurobiol 1992;6:225-37
43. Brismar T, Sima AA. Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis. Acta Physiol Scand 1981;113:499-506
44. Horn S, Quasthoff S, Grafe P, Bostock H, Renner R, Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve 1996;19:1268-75
45. Mattingly GE, Fischer VW. Peripheral nerve axonal dwindling with concomitant myelin sheath hypertrophy in experimentally induced diabetes. Acta Neuropathol 1985;68:149-54
46. Sima AAF, Lattimer SA, Yagihashi S, Greene DA. Axo-glial dysjunction: A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic biobreeding rat. J Clin Invest 1986;77:474-84
47. Ochodnicka E, Ochdnicky M, Belej K, Fusekova E, Bosel'ova L. Quantitative analysis of myelinated nerve fibers of peripheral nerve in streptozotocin-induced diabetes mellitus. Mol Chem Neuropathol 1995;25:225-33
48. Tamura E, Parry GJ. Severe radicular pathology in rats with long-standing diabetes. J Neurol Sci 1994;127:29-35
49. Gilmore SA. Spinal root degeneration in aging laboratory rats: A light microscopic study. Anat Rec 1972;174:251-57
50. Krinke G, Suter J, Hess R. Radicular myelinopathy in aging rats. Vet Pathol 1981;18:335-41
51. Berge BN, Wolf A, Simms HS. Degenerative lesions of spinal roots and peripheral nerves in aging rats. Gerontologia 1994;6:72-80
52. Graham DI, Gonatas NK. Triethyltin sulfate-induced splitting of peripheral myelin in rats. Lab Invest 1973;29:628-32
53. Towfighi J, Gonatas NK, McCree L. Hexachlorophene neuropathy in rats. Lab Invest 1973;29:428-36
54. Anderson TD, Davidovich A, Feldman D, et al. Mitochondrial Schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Lab Invest 1994;70:724-39
55. 6 in rat primary sensory neurons. J Neuropathol Exp Neurol 1985;44:117-29
56. Sensi M, Pricci F, Pugliese G. Role of advanced glycation end-products (AGE) in late diabetic complications. Diabetes Res Clin Practise 1995;28:9-17